Federal contract award
15B50525F00000116
OPSUMIT 10MG-QTY 6 @ 6,270.03 UPTRAVI 1600MCG QTY 1 @ 22,743.10 ADEMPAS 1MG, QTY 1 @ 12,153.05 MARCH 2025
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Justice |
| Office | FMC CARSWELL |
| NAICS | 622110 — General Medical and Surgical Hospitals |
| PSC | Q517 — Pharmacy Services |
| Parent award / vehicle | 15BFA022D00000007 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $34.9K |
| Current contract value | $72.5K |
| Potential contract value / ceiling | $72.5K |
| Start date | Mar 1, 2025 |
| Current end date | Mar 31, 2025 |
| Potential end date | Mar 31, 2025 |
| Latest award activity | Apr 15, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 15, 2025 | P00001 | $-37.6K | OPSUMIT 10MG-QTY 6 @ 6,270.03 UPTRAVI 1600MCG QTY 1 @ 22,743.10 ADEMPAS 1MG, QTY 1 @ 12,153.05 MARCH 2025 |
| Mar 3, 2025 | 0 | $72.5K | OPSUMIT 10MG-QTY 6 @ 6,270.03 UPTRAVI 1600MCG QTY 1 @ 22,743.10 ADEMPAS 1MG, QTY 1 @ 12,153.05 MARCH 2025 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.